Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


HIGGINS JOHN L Create: Alert

All | News | Filings
Date FiledTypeDescription
05/25/2023 4 HIGGINS JOHN L (Director) has filed a Form 4 on OmniAb, Inc.
Txns: Sold 9,000 shares @ $4.05, valued at $36.5k
Exercised 9,000 options @ $3.68, valued at $33.1k
05/23/2023 4 HIGGINS JOHN L (Director) has filed a Form 4 on OmniAb, Inc.
Txns: Sold 1,000 shares @ $4.05, valued at $4.1k
Exercised 1,000 options @ $3.68, valued at $3.7k
05/19/2023 4 HIGGINS JOHN L (Director) has filed a Form 4 on OmniAb, Inc.
Txns: Sold 50,000 shares @ $3.89, valued at $194.5k
Exercised 50,000 options @ $3.68, valued at $184k
05/18/2023 144 Form 144 - Report of proposed sale of securities:
05/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/30/2022 4 HIGGINS JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 5,289 shares @ $66.29, valued at $350.6k
12/20/2022 4 HIGGINS JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Sold 10,000 shares @ $61.8657, valued at $618.7k
12/14/2022 4 HIGGINS JOHN L (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Disposed/sold 3,944 shares @ $64.8, valued at $255.6k
Exercised 20,000 options to buy @ $12.78, valued at $255.6k
12/01/2022 4 HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 9,803 shares @ $72.9, valued at $714.6k
11/21/2022 4 HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Sold 10,000 shares @ $78.3173, valued at $783.2k
Exercised 10,000 options to buy @ $12.78, valued at $127.8k
11/07/2022 4/A HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
11/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
09/22/2022 4/A HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Sold 1,000 shares @ $88.06, valued at $88.1k
09/16/2022 4 HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Sold 2,000 shares @ $90, valued at $180k
Sold 3,000 shares @ $89.35, valued at $268.1k
08/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2022 4 HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 1,946 shares @ $123.68, valued at $240.7k
Paid exercise price by delivering 2,061 shares @ $123.68, valued at $254.9k
Paid exercise price by delivering 1,916 shares @ $123.68, valued at $237k
02/07/2022 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
01/28/2022 4 HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Granted 9,606 shares @ $0
Granted 13,560 shares @ $0
Paid exercise price by delivering 3,060 shares @ $113.68, valued at $347.9k
Paid exercise price by delivering 6,183 shares @ $113.68, valued at $702.9k
11/12/2021 4 HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Sold 3,000 shares @ $160.5, valued at $481.5k
11/01/2021 4 HIGGINS JOHN L (Director) has filed a Form 4 on BIO-TECHNE Corp
Txns: Granted 194 shares @ $0
Granted 633 options to buy @ $515.24, valued at $326.1k
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/27/2021 4 HIGGINS JOHN L (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC
Txns: Sold 50,000 shares @ $159, valued at $8M
Granted 5,946 shares @ $0
Paid exercise price by delivering 2,845 shares @ $156.01, valued at $443.8k
Granted 9,607 shares @ $0
Paid exercise price by delivering 4,596 shares @ $156.01, valued at $717k
Sold 40,000 shares @ $182, valued at $7.3M
Exercised 50,000 options to buy @ $14.47, valued at $723.5k
Exercised 40,000 options to buy @ $14.47, valued at $578.8k
Exercised 30,000 options to buy @ $21.92, valued at $657.6k
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy